| dbo:abstract
|
- Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease (AD). This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well as those who may develop AD and controls with no signs of cognitive impairment. Researchers at 63 sites in the US and Canada track the progression of AD in the human brain with neuroimaging, biochemical, and genetic biological markers. This knowledge helps to find better clinical trials for the prevention and treatment of AD. ADNI has made a global impact, firstly by developing a set of standardized protocols to allow the comparison of results from multiple centers, and secondly by its data-sharing policy which makes available all at the data without embargo to qualified researchers worldwide. To date, over 1000 scientific publications have used ADNI data. A number of other initiatives related to AD and other diseases have been designed and implemented using ADNI as a model. ADNI has been running since 2004 and is currently funded until 2021. (en)
- 알츠하이머병 뇌영상 선도연구 (Alzheimer’s Disease Neuroimaging Initiative, ADNI)는 알츠하이머병의 진단과 치료를 위한 임상 시험 개선을 목적으로 하는 멀티사이트 연구이다. 이 연구는 알츠하이머병과 인지적 손상의 징후가 없는 대조군을 연구하기 위해 민간 및 공공 분야의 자금 후원과 전문 분야의 지식을 결합한 협력연구이다. 미국과 캐나다의 63개 지역 연구진들이 뇌영상과 생화학, 유전적 생물학 마커를 활용하여 알츠하이머병의 진행과정을 추적한다. (ko)
|
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 43906 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- 알츠하이머병 뇌영상 선도연구 (Alzheimer’s Disease Neuroimaging Initiative, ADNI)는 알츠하이머병의 진단과 치료를 위한 임상 시험 개선을 목적으로 하는 멀티사이트 연구이다. 이 연구는 알츠하이머병과 인지적 손상의 징후가 없는 대조군을 연구하기 위해 민간 및 공공 분야의 자금 후원과 전문 분야의 지식을 결합한 협력연구이다. 미국과 캐나다의 63개 지역 연구진들이 뇌영상과 생화학, 유전적 생물학 마커를 활용하여 알츠하이머병의 진행과정을 추적한다. (ko)
- Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease (AD). This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well as those who may develop AD and controls with no signs of cognitive impairment. Researchers at 63 sites in the US and Canada track the progression of AD in the human brain with neuroimaging, biochemical, and genetic biological markers. This knowledge helps to find better clinical trials for the prevention and treatment of AD. ADNI has made a global impact, firstly by developing a set of standardized protocols to allow the comparison of results from multiple centers, and secondly by its data-sharing p (en)
|
| rdfs:label
|
- Alzheimer's Disease Neuroimaging Initiative (en)
- 알츠하이머병 뇌영상 선도연구 (ko)
|
| owl:sameAs
| |
| skos:closeMatch
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
